Search

for
Search:

Sort by

Research

240-270 / 1000+ results

research Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)

63 citations , July 2024 in “Journal of the American Academy of Dermatology”

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Dutasteride, A Novel Dual 5-Alpha Reductase Inhibitor, Reduces Serum DHT to a Greater Extent Versus Finasteride and Achieves Maximal Reduction in a Larger Proportion of Patients

research Dutasteride, a novel dual 5-A reductase inhibitor, reduces serum DHT to a greater extent versus finasteride and achieves finasteride maximal reduction in a larger proportion of patients

12 citations , February 2003 in “European Urology Supplements”

Dutasteride reduces DHT more effectively than finasteride.

research Combination oral minoxidil and spironolactone for the treatment of androgenetic alopecia in adolescent females / supplemental files

November 2020

research A New Topical Formulation of Minoxidil and Finasteride Improves Hair Growth in Men with Androgenetic Alopecia

5 citations , January 2015 in “Journal of clinical & experimental dermatology research”

MorrF improves hair growth better than minoxidil alone.

research Dutasteride

January 2025

Dutasteride may become the top choice for treating hair loss.

Safety and Efficacy of Trimax-360 Serum in Healthy Adult Subjects with Mild to Moderate Alopecia of the Scalp

research Safety and efficacy of Trimax‐360 serum in healthy adult subjects with mild to moderate alopecia of scalp

April 2022 in “Journal of Cosmetic Dermatology”

Trimax-360 Serum, when used for 98 days, safely and effectively improves hair growth, thickness, and density without any side effects.

research BENIGN PREMATURE ADRENARCHE: CLINICAL FEATURES AND SERUM STEROID LEVELS

77 citations , September 1983 in “Acta Paediatrica”

Dexamethasone effectively normalizes elevated steroid levels in girls with premature adrenarche.

research A New Era of 5α-Reductase Inhibitors for Androgenetic Alopecia

1 citations , January 2015 in “Hair therapy & transplantation”

New drug dutasteride effectively treats hair loss, but use cautiously due to potential sexual side effects.

research Therapeutic Androgen Receptor Ligands

16 citations , January 2003 in “Nuclear Receptor Signaling”

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

research An update on the treatment of female alopecia and the introduction of a potential novel therapy

3 citations , August 2015 in “Clinical and Experimental Obstetrics & Gynecology”

Minoxidil is the only drug proven to improve female hair loss, and dextroamphetamine sulfate may be a new treatment for certain types of hair loss.

research Cortexolone 17a-propionate: A new antiandrogen acting on hair dermal papilla cells for the treatment of androgenic alopecia

March 2014 in “Journal of The American Academy of Dermatology”

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

research WS PRO 160 I 120 mg (a combination of sabal and urtica extract) in patients with LUTS related to BPH

3 citations , January 2019 in “Therapeutic advances in urology”

WS PRO 160 I 120 mg effectively treats urinary symptoms from BPH with good safety and tolerability.

Dose-Dependent Increases in Carotid Intima-Media Thickness Associated with Oral Minoxidil but Not Dutasteride in Healthy Young Males: A Randomized Controlled Pharmacological Trial

research Dose-Dependent Increases in Carotid Intima-Media Thickness Associated with Oral Minoxidil but Not Dutasteride in Healthy Young Males: A Randomized Controlled Pharmacological Trial

June 2026 in “Preprints.org”

Oral minoxidil can harm arteries at higher doses, while dutasteride may be safer.

research Discovery of an Androgen Receptor Degrader Featuring a Pyridazinyl Glutarimide CRBN-Binding Motif for Transdermal Treatment of Androgenetic Alopecia

May 2026 in “Journal of Medicinal Chemistry”

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

research FINASTERIDE AND PSA

November 2005 in “The Journal of Urology”

research COMBINATION OF AN ANTIANDROGEN AND A 5α-REDUCTASE INHIBITOR: A FURTHER STEP TOWARDS TOTAL ANDROGEN BLOCKADE?

9 citations , March 1991 in “Endocrinology”

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Pharmacy Avenue - Guimarães and in the Pharmaceutical Services of the Local Health Unit of Alto Ave, EPE - Guimarães

research Farmácia Avenida - Guimarães e nos Serviços Farmacêuticos da Unidade Local de Saúde do Alto Ave, EPE - Guimarães

October 2025 in “Open Repository of the University of Porto (University of Porto)”

Pharmacists play a crucial role in personalized therapy, health literacy, and patient care across various health conditions.

research Market Analysis of 5α-Reductase Inhibitor

January 2006 in “Zhongguo yaofang”

The market for these drugs is expected to grow.

research Randomized clinical trial of astaxanthin supplement on serum inflammatory markers and ER stress‐apoptosis gene expression in PBMCs of women with PCOS

19 citations , July 2024 in “Journal of Cellular and Molecular Medicine”

Astaxanthin may reduce inflammation in women with PCOS, but doesn't significantly improve symptoms.

Efficacy and Safety of 3% Minoxidil Versus Combined 3% Minoxidil / 0.1% Finasteride in Male Pattern Hair Loss: A Randomized, Double-Blind, Comparative Study

research Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study.

6 citations , October 2012 in “PubMed”

The combined treatment of 3% minoxidil and 0.1% finasteride is more effective in improving hair loss than 3% minoxidil alone, with similar side effects.